Study to Evaluate Safety & Tolerability of AGI-134 in Solid Tumour
Clinical trial NCT03593226 · COMPLETED
Trial details
- NCT number
- NCT03593226
- Sponsor
- Agalimmune Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-30
- Primary completion
- 2023-12-31
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.